Earleywine M

Psychology, State University of New York, Albany, NY, USA.

15 papers · 1 preprint · ORCID

ArticlePsychedelics

Psychedelic Use Covaries with Psychological Flexibility Through Mystical Experiences: Results of a Retrospective Web Survey.

Spata A, Sturges JW, Earleywine M

Europe PMC2026
ArticleMDMA

Blinding, Expectancy, and the Active Placebo Paradox in MDMA Research.

Earleywine M, Allen Q

Europe PMC2026
ArticlePsychedelics

Intention-Setting Among Recreational Psychedelic Users: Associated Acute Effects and Changes in Well-Being.

Low F, Earleywine M

Europe PMC2026
ArticlePsilocybin

Perceptions of Psilocybin-Assisted Psychotherapy and Standard Interventions for Nicotine Cessation.

Kamilar-Britt P, Oliva AB, Earleywine M

Europe PMC2026
ArticleMDMA

Questions and Concerns About MDMA-Assisted Therapy (MDMA-AT) in Veterans with PTSD Symptoms.

Earleywine M, Holley C, MacConnel H +1

Europe PMC2025
ArticlePsychedelics

Examining Volunteer Bias in Psychedelic Research.

Gomez SG, Low F, Earleywine M

Europe PMC2025
ArticleDMT

Inhaled Dimethyltryptamine (DMT): Use Patterns and Predictors of Consumption Frequency.

Parnes JE, Earleywine M

Europe PMC2025
ArticleKetamine

Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm.

MacConnel HA, Earleywine M, Radowitz S

Europe PMC2025
ArticlePsychedelics

Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects.

Earleywine M, Gomez SG

Europe PMC2024
ArticleKetamine

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Yermus R, Bottos J, Bryson N +18

Europe PMC2024
PreprintKetamine

Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm

MacConnel HA, Earleywine M, Radowitz S

Europe PMC2024
ArticlePsychedelics

The Therapeutic Alliance in Psychedelic-Assisted Psychotherapy: A Novel Target for Research and Interventions.

Kamilar-Britt P, Gordis EB, Earleywine M

Europe PMC2023
ArticlePsychedelics

Development of the Protective Strategies for Psychedelics Scale: A novel inventory to assess safety strategies in the context of psychedelics.

Mian MN, Altman BR, Low F +1

Europe PMC2024
ArticlePsilocybin

Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials.

Herrmann Z, Earleywine M, De Leo J +3

Europe PMC2023
ArticlePsychedelics

Expectancies for Cannabis- Induced Emotional Breakthrough, Mystical Experiences and Changes in Dysfunctional Attitudes: Perceptions of the Potential for Cannabis-Assisted Psychotherapy for Depression.

Earleywine M, Mian MN, Altman BR +1

Europe PMC2022
ArticlePsilocybin

Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.

Altman BR, Earleywine M, De Leo J

Europe PMC2022